Neogen Corporation

Neogen Corporation

NEOG · Nasdaq

Neogen Corporation (NEOG) is a Medical diagnostics research company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Neogen Corporation in 2026. The next earnings report is expected on October 8, 2026.

Earnings calendar

Next earnings date

08 Oct 2026

In 48 days

EPS estimate

0.05

Revenue estimate

206.3M

Past earnings

30 Jul 2026
EPS actual
0.09 (+8.0%)
estimate 0.08
Revenue actual
225.3M (+3.2%)
estimate 218.3M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
09 Apr 2026
EPS actual
0.09 (+54.8%)
estimate 0.06
Revenue actual
211.2M (+3.3%)
estimate 204.5M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
08 Jan 2026
EPS actual
0.10 (+58.1%)
estimate 0.06
Revenue actual
224.7M (+8.2%)
estimate 207.7M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Beat Miss usd

Latest earnings analysis

Neogen Corporation beat consensus estimates in its latest earnings report, with EPS of $0.09 coming in 8.0% above expectations and revenue of $225.3 million exceeding estimates by 3.2%. In the previous report both EPS and revenue also came in ahead of expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Sector
Healthcare
Industry
Medical diagnostics research
Country
United States
Exchange
Nasdaq
CEO
Mikhael Nassif
Employees
2,917
IPO date
23 Aug 1989
ISIN
US6404911066
Website
neogen.com

Frequently asked questions

When does Neogen Corporation (NEOG) next report earnings?

Neogen Corporation (NEOG) is scheduled to report earnings on October 8, 2026.

What was Neogen Corporation's most recent earnings date?

Neogen Corporation (NEOG) last reported earnings on July 30, 2026.

Where is Neogen Corporation stock listed?

Neogen Corporation (NEOG) is listed on Nasdaq.